Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 3/20 | 0.82 |
| ▸ | FLT3 | P36888 | 3/20 | 0.82 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.82 |
| ▸ | IP6K2 | Q9UHH9 | 2/20 | 0.82 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.82 |
| ▸ | CDK8 | P49336 | 3/20 | 0.78 |
| ▸ | CCNC | P24863 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 4/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.74 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Techtochrysin SCHEMBL29494561 | 1.00 | MAPT (1.00) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| Genkwanin SCHEMBL29445006 | 0.90 | FLT3 (1.00) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| Genkwanin SCHEMBL866123 | 0.90 | FLT3 (1.00) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| Apigenin Dimethylether SCHEMBL1176691 | 0.90 | MAOB (1.00) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| Apigenin Dimethylether SCHEMBL29392759 | 0.90 | MAOB (1.00) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| Genkwanin SCHEMBL2464219 | 0.89 | CYP3A4 (0.80) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| SCHEMBL22729259 | 0.89 | MAPT (0.81) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| Chrysin SCHEMBL28168227 | 0.89 | MAPT (0.89) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| SCHEMBL28762810 | 0.89 | MAPT (0.79) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 | |
| SCHEMBL28762731 | 0.88 | CDK8 (1.00) | MAPTCYP3A4ABCB1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | MARUZEN PHARM CO LTD (JP) | 2026-04-30 | — | — | US | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-12-04 | — | — | US | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| WO-2024177490-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | 서울대학교산학협력단 | 2024-08-29 | — | — | WO | claimed |
| CN-114867486-B | Composition containing black ginger extract and composition for oral administration | 丸善制药株式会社 | 2023-05-30 | — | — | CN | claimed |
| US-11596657-B2 | Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2023-03-07 | — | — | US | claimed |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | MARUZEN PHARMACEUTICALS CO., LTD. (JP) | 2023-01-19 | — | — | US | claimed |
| CN-115475157-A | Intestinal barrier improving agent | 株式会社资生堂 | 2022-12-16 | — | — | CN | claimed |
| CN-101423507-A | Preparation of poplar antibacterial compounds and application thereof as bactericidal agent | UNIV CHINA AGRICULTURAL (CN) | 2009-05-06 | — | — | CN | claimed |
| EP-1067913-A4 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE LLC (US) | 2009-03-11 | — | — | EP | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | claimed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | claimed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | claimed |
| WO-2001003687-A2 | METHOD AND COMPOSITIONS FOR INHIBITING BIOSYNTHESIS OR BIOACTIVITY OF ENDOGENOUS STEROID SEX HORMONES IN HUMANS | CEDARS-SINAI MEDICAL CENTER (US) | 2001-01-18 | — | — | WO | claimed |
| EP-1067913-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | Bioresponse, L.L.C. (US) | 2001-01-17 | — | — | EP | claimed |
| WO-1999049851-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE, L.L.C. (US) | 1999-10-07 | — | — | WO | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | CYP4F8, CYP4F2, CYP4F11 | MAPT 1398/4885CYP3A4 8/4885ABCB1 159/4885 |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | CYP4F8, CYP4F2, CYP4F11 | MAPT 842/4885CYP3A4 11/4885ABCB1 98/4885 |
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | ALB, TNNC1, MYOF | MAPT 629/4885CYP3A4 4025/4885ABCB1 3875/4885 |
| US-20040057908-A1 | Oral compositions and use thereof | UGGT1, DPM1, B4GALT1 | MAPT 1260/4885CYP3A4 269/4885ABCB1 1086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.